Wockhardt, Laurus, Aurobindo To Biocon: What Fuelled Pharma Stocks Bullish Run?

Pharma Stocks Rally: Shares of pharmaceutical companies including Wockhardt Limited, Divi's Laboratories, Laurus Labs, Aurobindo Pharma, Bicon, etc rallied during Friday's trading session. The bullish sentiment in pharma stocks came hours after United States President Donald Trump signed the FY2026 National Defence Authorisation Act into law.

Laurus Labs shares closed 3.19% higher at Rs 1,047.90 per share, Wockhardt Pharma shares surged 2.36% to close higher at Rs 1,412 per share, whereas Glenmark shares closed 1.78% higher at Rs 1,992 per share.

Why Pharma Stocks Surged On Friday?

The jump in pharma stocks today came after the US Senate cleared the 'Biosecure Act'. It is a part of a larger defence bill which aims to curb some Chinese biotech companies and their access to federal funding.

The development has likely raised investors optimisim around the growth prospects of Indian suppliers to US healthcare and defence-linked firms.

What is Biosecure Act?

The Biosecure Act formed part of the fiscal 2026 National Defence Authorisation Act, a package of almost $1 trillion that sets Pentagon policy and funding and has now passed both chambers of the US Congress for the 65th consecutive year, awaiting US President Donald Trump's signature at the White House.

The latest version of the Biosecure Act, first floated in 2024 but not cleared then, seeks to reduce China's role in US biotech supply lines and aims to safeguard American facilities from biotech espionage by preventing some Chinese biotech players from receiving federal funding, although the present text does not list specific companies.

According to experts, India can emerge as one of the key beneficiaries as US policymakers attempt to limit China's influence within biotechnology, prompting some American clients to reassess procurement strategies and giving Indian pharma stocks a boost as investors anticipated higher outsourcing orders over the medium term.

Top Pharma Gainers Today

Mankind Pharma, Lupin, Glenmark Pharmaceuticals, Zydus Lifesciences, Abbott India, Sun Pharmaceutical Industries, IPCA Laboratories and Dr. Reddy's Laboratories traded in positive territory. Their moves were modest but still contributed to the broader sector strength, keeping the Nifty Pharma index largely supported through the session.

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.